Dr. Douglas W Blayney, MD is a Hematology / Oncology Specialist - Oncologist (Cancer), Internist - General practicing in Stanford, CA
He has not yet shared a personalized biography with Doctor.com.… Read more ›
University | Degree | Focus | Graduated |
---|---|---|---|
University of Ca, San Diego, School of Medicine LA Jolla Ca | Other Degree | 1977 |
Institution | Focus | Year |
---|---|---|
Internship - Usc Hosp | Not Specified | |
Residency - University Ca San Diego Medical Center, Internal Medicine | Not Specified | |
Residency - UCSD School of Medicine | 1980 | |
Fellowship - Medicine Branch, National Cancer Institute, Bethesda, Maryland | 1983 |
Certification | Cert. Body | Year |
---|---|---|
Internal medicine | Internal Medicine | Not Specified |
Sub-Specialty: Medical Oncology | Internal Medicine | 1983 |
Internal medicine | Internal Medicine | 1980 |
Position | Organization | Time |
---|---|---|
Professor of Medicine (Oncology) | the Stanford University Medical center | Present |
Publication | Publisher | Title | Published |
---|---|---|---|
Other Publication | Jourl of oncology practice / American Society of Clinical Oncology | Transforming cancer care: are transdiscipliry approaches using design-thinking, engineering | 2014 |
Other Publication | Jourl of clinical oncology | American society of clinical oncology 2013 top five list in oncology. | 2013 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | ASCO's Quality Care Symposium (November 1-2, 2013) Abstracts | 2013 |
Other Publication | Jourl of oncology practice / American Society of Clinical Oncology | Computerized prescriber order entry implementation in a physician assistant-maged hematology | 2013 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Measuring the Improving Quality of Outpatient Care in Medical Oncology Practices in the United | 2013 |
Other Publication | JNCI-JOURL OF THE TIOL CANCER INSTITUTE | Tumor Boards (Team Huddles) Aren't Enough to Reach the Goal | 2013 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Adoption of Gene Expression Profile Testing | 2012 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care | 2012 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Enhancing Quality Through Innovation | 2010 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Implementation of the Quality Oncology Practice Initiative at a University Comprehensive Cancer | 2009 |
Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Myeloid Growth Factors | 2013 |
Other Publication | Jourl of oncology practice / American Society of Clinical Oncology | Measuring and improving quality of care in an academic medical center. | 2013 |
Other Publication | BLOOD | Comparative outcome of initial therapy for younger patients with mantle cell lymphoma | 2012 |
Other Publication | BREAST CANCER RESEARCH AND TREATMENT | The impact of obesity on receipt of adjuvant chemotherapy for breast cancer | 2011 |
Other Publication | Jourl of oncology practice / American Society of Clinical Oncology | Commentary: six years of trends in oncology practice data. | 2011 |
Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Myeloid Growth Factors | 2011 |
Other Publication | ANLS OF SURGERY | Institutiol Variation in the Surgical Treatment of Breast Cancer A Study of the NCCN | 2011 |
Other Publication | ONCOLOGIST | Continued Use of Trastuzumab Beyond Disease Progression in the tiol Comprehensive Cancer Network | 2011 |
Other Publication | Jourl of oncology practice / American Society of Clinical Oncology | Challenges to tiol Cancer Institute-Supported Cooperative Group Clinical Trial Participation | 2010 |
Other Publication | Jourl of oncology practice / American Society of Clinical Oncology | Partnering with payers for success | 2009 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy | 2009 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer | 2008 |
Other Publication | JOURL OF THE AMERICAN COLLEGE OF SURGEONS | The registry case finding engine | 2007 |
Other Publication | Jourl of oncology practice / American Society of Clinical Oncology | Defining Quality: QOPI Is a Start. | 2006 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin | 2003 |
Other Publication | NEW ENGLAND JOURL OF MEDICINE | DECREASING RISK OF LEUKEMIA WITH PROLONGED FOLLOW | 1987 |
Other Publication | JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION | THE HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUS IN THE SOUTHEASTERN UNITED-STATES | 1983 |
Other Publication | ANLS OF INTERL MEDICINE | THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS, LYMPHOMA, LYTIC BONE-LESIONS, AND HYPERCALCEMIA | 1983 |
Other Publication | Journal of oncology practice / American Society of Clinical Oncology | Transforming cancer care: are transdisciplinary approaches using design-thinking, engineering | 2014 |
Other Publication | Cancer | Breast cancer treatment across health care systems | 2014 |
Other Publication | Journal of clinical oncology | American society of clinical oncology 2013 top five list in oncology. | 2013 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | ASCO's Quality Care Symposium (November 1-2, 2013) Abstracts | 2013 |
Other Publication | Journal of oncology practice / American Society of Clinical Oncology | Computerized prescriber order entry implementation in a physician assistant-managed hematology | 2013 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Measuring the Improving Quality of Outpatient Care in Medical Oncology Practices in the United | 2013 |
Other Publication | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | Tumor Boards (Team Huddles) Aren't Enough to Reach the Goal | 2013 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Adoption of Gene Expression Profile Testing | 2012 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care | 2012 |
Other Publication | HEALTH AFFAIRS | Michigan Oncology Practices Showed Varying Adherence Rates To Practice Guidelines | 2012 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Enhancing Quality Through Innovation | 2010 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Implementation of the Quality Oncology Practice Initiative at a University Comprehensive Cancer | 2009 |
Other Publication | CANCER | Breast Cancer Treatment Across Health Care Systems | 2014 |
Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Myeloid Growth Factors | 2013 |
Other Publication | Journal of oncology practice / American Society of Clinical Oncology | Measuring and improving quality of care in an academic medical center. | 2013 |
Other Publication | BREAST CANCER RESEARCH AND TREATMENT | Time to diagnosis and breast cancer stage by race/ethnicity | 2012 |
Other Publication | CANCER | Clinicopathologic Features, Patterns of Recurrence | 2012 |
Other Publication | QUALITY OF LIFE RESEARCH | The anemia impact measure (AIM) | 2012 |
Other Publication | ONCOLOGIST | The Effect of Age on Delay in Diagnosis and Stage of Breast Cancer | 2012 |
Other Publication | BLOOD | Comparative outcome of initial therapy for younger patients with mantle cell lymphoma | 2012 |
Other Publication | BREAST CANCER RESEARCH AND TREATMENT | The impact of obesity on receipt of adjuvant chemotherapy for breast cancer | 2011 |
Other Publication | Journal of oncology practice / American Society of Clinical Oncology | Commentary: six years of trends in oncology practice data. | 2011 |
Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Myeloid Growth Factors | 2011 |
Other Publication | ANNALS OF SURGERY | Institutional Variation in the Surgical Treatment of Breast Cancer A Study of the NCCN | 2011 |
Other Publication | ONCOLOGIST | Continued Use of Trastuzumab Beyond Disease Progression | 2011 |
Other Publication | LANCET | Expansion of cancer care and control in countries of low and middle income: a call to action | 2010 |
Other Publication | Journal of oncology practice / American Society of Clinical Oncology | Challenges to National Cancer Institute-Supported Cooperative Group Clinical Trial Participation | 2010 |
Other Publication | Journal of oncology practice / American Society of Clinical Oncology | Partnering with payers for success | 2009 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy | 2009 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer | 2008 |
Other Publication | JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | The registry case finding engine | 2007 |
Other Publication | Journal of oncology practice / American Society of Clinical Oncology | Defining Quality: QOPI Is a Start. | 2006 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin | 2003 |
Other Publication | NEW ENGLAND JOURNAL OF MEDICINE | DECREASING RISK OF LEUKEMIA WITH PROLONGED FOLLOW | 1987 |
Other Publication | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | THE HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUS IN THE SOUTHEASTERN UNITED-STATES | 1983 |
Other Publication | ANNALS OF INTERNAL MEDICINE | THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS, LYMPHOMA, LYTIC BONE-LESIONS, AND HYPERCALCEMIA | 1983 |
Other Publication | BLOOD | THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS ASSOCIATED WITH AMERICAN ADULT T-CELL LEUKEMIA LYMPHOMA | 1983 |
Dr. Douglas W Blayney, MD has not yet indicated the hospitals that he is affiliated with.
Internal Medicine
Accepts New Patients: Yes
Dr. Douglas W Blayney, MD has not yet listed the medications that he commonly prescribes.
Dr. Douglas W Blayney, MD has not yet added any information about his practice's billing policies and payment options.